Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 27 of 27 entries
Sorted by: Best Match Show Resources per page
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient.

Journal of diabetes and its complications

De Vincentis A, Antonelli-Incalzi R, Picardi A, Vespasiani-Gentilucci U.
PMID: 33642147
J Diabetes Complications. 2021 May;35(5):107891. doi: 10.1016/j.jdiacomp.2021.107891. Epub 2021 Feb 18.

No abstract available.

Cite
De Vincentis A, Antonelli-Incalzi R, Picardi A, et al. Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient. J Diabetes Complications. 2021;35(5):107891doi: 10.1016/j.jdiacomp.2021.107891.
De Vincentis, A., Antonelli-Incalzi, R., Picardi, A., & Vespasiani-Gentilucci, U. (2021). Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient. Journal of diabetes and its complications, 35(5), 107891. https://doi.org/10.1016/j.jdiacomp.2021.107891
De Vincentis, Antonio, et al. "Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient." Journal of diabetes and its complications vol. 35,5 (2021): 107891. doi: https://doi.org/10.1016/j.jdiacomp.2021.107891
De Vincentis A, Antonelli-Incalzi R, Picardi A, Vespasiani-Gentilucci U. Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient. J Diabetes Complications. 2021 May;35(5):107891. doi: 10.1016/j.jdiacomp.2021.107891. Epub 2021 Feb 18. PMID: 33642147.
Copy Download .nbib Format: NLM
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply.

Alimentary pharmacology & therapeutics

Park JG, Jung J, Loomba R.
PMID: 34170539
Aliment Pharmacol Ther. 2021 Jul;54(2):216. doi: 10.1111/apt.16462.

No abstract available.

Cite
Park JG, Jung J, Loomba R. Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply. Aliment Pharmacol Ther. 2021;54(2):216doi: 10.1111/apt.16462.
Park, J. G., Jung, J., & Loomba, R. (2021). Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply. Alimentary pharmacology & therapeutics, 54(2), 216. https://doi.org/10.1111/apt.16462
Park, Jung Gil, et al. "Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply." Alimentary pharmacology & therapeutics vol. 54,2 (2021): 216. doi: https://doi.org/10.1111/apt.16462
Park JG, Jung J, Loomba R. Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply. Aliment Pharmacol Ther. 2021 Jul;54(2):216. doi: 10.1111/apt.16462. PMID: 34170539.
Copy Download .nbib Format: NLM
The Evolving Challenge of Infections in Cirrhosis.

The New England journal of medicine

Haidar G, Singh N.
PMID: 34525295
N Engl J Med. 2021 Sep 16;385(12):1150-1151. doi: 10.1056/NEJMc2111760.

No abstract available.

Cite
Haidar G, Singh N. The Evolving Challenge of Infections in Cirrhosis. N Engl J Med. 2021;385(12):1150-1151doi: 10.1056/NEJMc2111760.
Haidar, G., & Singh, N. (2021). The Evolving Challenge of Infections in Cirrhosis. The New England journal of medicine, 385(12), 1150-1151. https://doi.org/10.1056/NEJMc2111760
Haidar, Ghady, and Singh, Nina. "The Evolving Challenge of Infections in Cirrhosis." The New England journal of medicine vol. 385,12 (2021): 1150-1151. doi: https://doi.org/10.1056/NEJMc2111760
Haidar G, Singh N. The Evolving Challenge of Infections in Cirrhosis. N Engl J Med. 2021 Sep 16;385(12):1150-1151. doi: 10.1056/NEJMc2111760. PMID: 34525295.
Copy Download .nbib Format: NLM
Showing 25 to 27 of 27 entries